Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 150 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1491 7.5 months metastatic melanoma 5 Chemotherapy
Immunotherapy
Beth Israel Deaconess Medical Center United States 10/2002
Treatment Details: Patients: This Phase II study involved 48 patients with metastatic melanoma. Treatment: The treatment consisted of chemotherapy (cisplatin, vinblastine, temozolomide) and immunotherapy
 
1492 7.5 months Advanced renal cell carcinoma 3 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 9/2004
Treatment Details: Patients: This Phase II study involved 37 patients with advanced renal cell carcinoma, 26 men and 11 women. The median age was 64. Twenty-three patients had undergone prior nephrectomy.
 
1493 7.5 months Advanced NSCLC 5 Biologic therapy
Kyoto University Hospital Japan 4/2011
Treatment Details: Patients: This study involved 48 patients with previously treated advanced non-small cell lung cancer. The median age of the group was 62 years and 52% were male. Treatment: Patients w
 
1494 7.5 months Metastatic melanoma 4 Biologic therapy
The University of Texas M.D. Anderson Cancer Center United States 9/2008
Treatment Details: Patients: This phase 2 study involved 21 patients with metastatic melanoma. The median age of the patient group was 58 (range of 33-83) years and 62% were male. Treatment: Patients wer
 
1495 7.5 months Melanoma 4 Chemotherapy
Moffitt Cancer Center United States 4/2009
Treatment Details: Patients: This study involved 39 melanoma patients. The median age was 61 years (range 29-89) and 74% were male. Treatment: Patients were given two chemotherapy agents, karenitecin (a
 
1496 7.5 months GBM 5 Radiation
Linköping University Sweden 9/2012
Treatment Details: Patients: This phase 3 study involved newly diagnosed glioblastoma patients, all older than 60 years, who were divided into three separate treatment groups. Group A was composed of 93 pati
 
1497 7.4 months Advanced NSCLC 5 Biologic therapy
Winship Cancer Institute, Emory University United States 9/2012
Treatment Details: Patients: This phase 2 study involved advanced non-small-cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 94 patients with a median age o
 
1498 7.4 months Advanced hepatocellular carcinoma 4 Biologic therapy
Chemotherapy
National Taiwan University Hospital Taiwan Region 7/2010
Treatment Details: Patients: This phase II study involved 53 patients with advanced hepatocellular carcinoma. The median patient age was 57 years and 89% were male. Treatment: Patients were treated with
 
1499 7.4 months Metastatic or unresectable liver cancer 4 Chemotherapy
California Pacific Medical Center United States 7/2007
Treatment Details: Patients: This phase III study involved 445 patients with unresectable or metastatic hepatocellular carcinoma (liver cancer). Treatment: The patients were divided into two groups; o
 
1500 7.4 months Recurrent NSCLC 5 Chemotherapy
University Hospital Italy 4/2006
Treatment Details: Patients: This Phase II study involved 40 patients (30 men, 10 women, median age 60) with advanced non-small-cell lung cancer. Thirty-three patients had received chemotherapy before the stu
 
Page 150 of 187  | Previous Page  | Next Page